NYSE$AGL

agilon health inc. · Q3 2020 earnings

Q3 2020 earnings · · Investor relations

Headline financials

Total Revenue

$313M

No prior period
EPS (adj)

-$0.03

No prior period
Medicare Advantage Members

128.7K

No prior period
Avg. MA Members

128.7K

No prior period
Net Income

-$11.8M

No prior period
Operating Income

-$9.84M

No prior period
Gross Profit

$25.4M

No prior period
R&D Expense

$0.00

No prior period

Revenue & EPS history

agilon health · Revenue · Quarterly

$313M

Q3 2020
Beat estimate in 11 of 11 quarters(100%)
ActualEstimate

Revenue by segment

agilon health · $313M total across 2 segments · Q3 2020

  • Medical Services Revenue
    $312M
  • Other Operating Revenue
    $950K

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports

Historical avg

-2.6%

Avg return

Earnings day

-0.0%

Avg return

5 days after

+6.7%

Avg return

30 days after

50%

10 / 20 earnings

Positive

+20.2%

Q4 2025

Best reaction

-36.1%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+4.2%+122.0%+256.9%
Q4 2025+20.2%+13.4%-20.8%
Q3 2025+5.1%-9.0%-9.9%
Q1 2025-25.6%-33.4%-51.6%
Q4 2024-7.4%-17.9%+23.7%
Q3 2024-36.1%-35.1%-24.7%
Q2 2024-12.7%-14.6%-36.8%
Q1 2024+7.5%+7.5%+40.8%
Q4 2023+3.1%-2.1%-1.1%
Q3 2023-13.1%-19.0%-33.1%
Q2 2023+0.7%+3.7%-7.9%
Q1 2023-3.4%-6.6%-18.9%
Q4 2022+15.4%+14.8%+12.0%
Q3 2022-12.7%-7.9%-8.6%
Q2 2022-3.3%-0.4%-20.3%
Q1 2022-8.6%-19.4%+1.3%
Q4 2021+10.6%+2.4%+31.7%
Q3 2021+2.7%+3.6%-9.5%
Q2 2021-3.8%-6.3%-3.4%
Q1 2021+6.3%+4.0%+14.0%
Q4 2020
Q3 2020
Q2 2020
Q1 2020
Q4 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro